Prestige Consumer Healthcare
241 hedge funds and large institutions have $2B invested in Prestige Consumer Healthcare in 2018 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 79 increasing their positions, 87 reducing their positions, and 36 closing their positions.
14% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 36
2% more funds holding
Funds holding: 237 → 241 (+4)
9% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 87
1.36% less ownership
Funds ownership: 126.32% → 124.96% (-1.4%)
19% less capital invested
Capital invested by funds: $2.48B → $2B (-$479M)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $935K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$17.8M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$15.3M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$11.6M |
| 4 |
BlackRock
New York
|
+$9.06M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.3M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$29.4M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$17.3M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$11.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.07M |
PBH Hedge Fund Activity: Q4 2018 in Review
241 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2018, worth a combined $2B — down 19% from $2.48B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new PBH positions and 36 closed out — a net gain of 5 holders — while 79 added to existing stakes and 87 trimmed.
The largest buyer was Rice Hall James & Associates, adding an estimated $17.8M. The largest seller was Fidelity Investments, cutting an estimated $30.3M.
- 241 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2018, up from 237 in Q3 2018.
- Funds reported $2B of Prestige Consumer Healthcare stock for Q4 2018, down 19% quarter-over-quarter.
- 41 funds opened new Prestige Consumer Healthcare positions in Q4 2018 and 36 closed out, a net change of +5 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2018 was Rice Hall James & Associates, an estimated $17.8M added.
- The largest Prestige Consumer Healthcare seller in Q4 2018 was Fidelity Investments, an estimated $30.3M sold.
Based on aggregated 13F filings for Q4 2018.